Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Carfilzomib SM1-N | C15H22N2O3 | 3063-05-6 | Details |
| Finipramine maleate EP Impurity A | C12H11N | 101-82-6 | Details |
| 1-Bromo-3-methyladamantane | C11H17Br | 702-77-2 | Details |
| Tetrapentyl propionate | C8H16O5 | 51690-77-8 | Details |
| Felodipine F3 isomer | C12H10Cl2O3 | 68064-69-7 | Details |
| 2-Hydrazino Adenosine | C10H15N7O4 | 15763-11-8 | Details |
| BPZ-29 Impurity Control | C16H22N2OS | 2549192-46-1 | Details |
| 4-(2-Chloroacetyl)benzonitrile | C9H6ClNO | 40805-50-3 | Details |
| 2-Acetoxyethyl 2-(2-fluoro-1.1'-biphenyl-4-yl)propionate | C19H19FO4 | 91503-88-7 | Details |
| 2-Ethylpropiophenone (717 Impurity) | C11H14O | 16819-79-7 | Details |
| C42H32N6O12 | 15596-27-7 | Details |
| C7H11NO5 | 774596-23-5 | Details |
| C7H6ClN3O | 3912-23-0 | Details |
| 2-Methoxy-6-methylphenol | C8H10O2 | 2896-67-5 | Details |
| Cefazoxime Double-Bond Reduction Impurity | C13H15N5O5S2 | 929101-89-3 | Details |
| 3-Nitrophenol | C6H5NO3 | 554-84-7 | Details |
| 4,5-Bismethylene-1,3-dioxolan-2-one | C5H4O3 | 62458-20-2 | Details |
| Topiroxostat Impurity | C12H9N5O | 36770-53-3 | Details |
| Impurity 12 isomer 1 | Details |
| 4-Amino-2-ethoxy-5-nitrobenzoic Acid Methyl Ester | C10H12N2O5 | 86718-17-4 | Details |
| Methyl 2-Nitrobenzenesulfonate | C7H7NO5S | 30384-53-3 | Details |
| Dobutamine Impurity 4 | C20H27NO3 | 140165-60-2 | Details |
| N-methyl-N-(napthalen-1-ylmethyl)nitrous amide | C12H12N2O | 296760-88-8 | Details |
| (2,4-difluorophenyl)-4-piperidinyl-Methanoneoxime | C12H14F2N2O | 691007-05-3 | Details |
| Nicotinamide N-oxide | C6H6N2O2 | 1986-81-8 | Details |
| Boc-His(Trt)-His(Trt)-OH | Details |
| Dobutamine Impurity 9 | C11H16O2 | 67952-38-9 | Details |
| 2,5-dimethoxyphenol | C8H10O3 | 18113-18-3 | Details |
| Flunarizine Impurity C | C26H26F2N2 | 90830-31-2 | Details |
| Glutamic acid reaction product with chloroacetyl chloride | C7H10ClNO5 | 56576-86-4 | Details |
| Impurity Trt-His(Trt)-OH | C44H37N3O2 | 74853-62-6 | Details |
| Wheel ring vine impurity 2 | Details |
| 2-((1S,5S,6S)-6-(aminomethyl)-3-(1-hydroxyethyl)dicyclo[3.2.0]heptan-3-en-6-yl)acetic acid benzenesulfonate reference substance | Details |
| Rivastigmine EP Impurity E | C13H20N2O2 | 923035-05-6 | Details |
| 1-(tetrahydro-2H-pyran-2-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | C14H23BN2O3 | 1279088-80-0 | Details |
| 6,6'-Dihydroxy-3,3'-bipyridine | C10H8N2O2 | 142929-10-0 | Details |
| (R)-2-chloro-1-(2,4-dichlorophenyl)ethan-1-ol | C8H7Cl3O | 114446-57-0 | Details |
| IMP-8 | C5H5IO3 | 80841-79-8 | Details |
| α-Isomemer | C10H12ClN5O4 | 60463-19-6 | Details |
| Methylatropine bromide | C18H26BrNO3 | 2870-71-5 | Details |
| Rivastigmine EP Impurity B | C13H20N2O2 | 1230021-28-9 | Details |
| Propyl ethyl sulfonate | C5H12O3S | 83314-76-5 | Details |
| (6R,7S)-7-TMCA | C10H12N6O3S2 | 126437-69-2 | Details |
| Tegafur Impurity 3 | C6H6ClNO2 | 1379260-15-7 | Details |
| Tocopherol | C29H50O2 | 1406-18-4 | Details |
| 4-Acetyl-2-methylbenzonitrile | C10H9NO | 1138444-80-0 | Details |
| tert-Butyl 2-methylaziridine-1-carboxylate | C8H15NO2 | 129319-91-1 | Details |
| N,N'-Bis-(4-chloro-phenyl)-hydrazine | C12H10Cl2N2 | 953-14-0 | Details |
| Dobutamine Impurity 43 | C17H21NO3 | 1059182-81-8 | Details |
| Pentoxifylline intermediate 1 | C9H14O3 | 10226-28-5 | Details |
| (R)-Flurbiprofen Axetil | C19H19FO4 | 2375240-97-2 | Details |
| Quaternary tetrapentyl dipropionate | 103839-42-5 | Details |
| Cabozantinib Impurity HF | C15H17NO6 | 213699-53-7 | Details |
| 1-Butylphosphoanhydride (50% ethyl acetate solution) | C12H27O6P3 | 163755-62-2 | Details |
| Methyl Tetrahydrofuran-2-Carboxylate | C6H10O3 | 37443-42-8 | Details |
| L-Kynurenine (Tryptophan Impurity C) | C10H12N2O3 | 343-65-7 | Details |
| Clevidipine Butyrate Impurity | C22H25Cl2NO6 | 1898262-47-9 | Details |
| 2-Cyanoisonicotinohydrazide | C7H6N4O | 135048-32-7 | Details |
| Reganoxen Impurity A | C14H15N7O6 | 313348-29-7 | Details |
| 4-Acetyl-2-methylbenzoicacidamide | C10H11NO2 | 1095275-06-1 | Details |
| Dibutyroxymethylcarboxylate impurity | C25H29Cl2NO8 | 253597-19-2 | Details |
| 5-acetyl-2-methylbenzoic acid | C10H10O3 | 1216048-89-3 | Details |
| Rivastigmine EP Impurity D | C14H22N2O2 | 415973-05-6 | Details |
| Lipoic acid impurity 7 | C8H15NOS2 | 940-69-2 | Details |
| C3H5N3S | 32362-75-7 | Details |
| Tetraacetylphytosphingosine | C26H47NO7 | 13018-48-9 | Details |
| 3-Ethyl 5-(1-methylethyl) 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | C20H23Cl2NO4 | 110962-80-6 | Details |
| 1H-1,2,4-triazol-5-thiol | Details |
| [(1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]heptan-3-en-6yl]tert-butyl acetate hydrochloride | Details |
| Topiramilast intermediate 2 | Details |
| Paliperidone Impurity F | Details |
| Paliperidone Impurity D (Nitrogen Oxide) | Details |
| XT-E Impurity 1 | Details |
| Vitamin K1 Impurity D | Details |
| Sitafloxacin ZZ-09 | Details |
| Aprexittan impurity I-4 | Details |
| CPC Derivatives 1 | Details |
| Product Total： Product Page： | ||||
| 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 | ||||